Cargando…

The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer

BACKGROUND: Folate-receptor alpha (FRα) is overexpressed in lung carcinoma. The FR-positive circulating tumor cell (FR+ CTC) has been established to be a non-invasive biomarker for lung cancer diagnosis. In this study, we sought to examine the value of FR+ CTC in the histological diagnosis of suspic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Xing, Wu, Shuo, Xu, Xi, Wu, Lei, Chang, Ning, Zhang, Jian, Ti, Xinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828523/ https://www.ncbi.nlm.nih.gov/pubmed/35242377 http://dx.doi.org/10.21037/jtd-21-1975

Ejemplares similares

The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer
por: Liu, Linjie, et al.
Publicado: (2017)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population
por: Li, Na, et al.
Publicado: (2019)

Folate receptor‐positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules
por: Li, Zhixin, et al.
Publicado: (2022)

Detection of folate receptor‐positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer
por: Wu, Qian, et al.
Publicado: (2021)

The value of folate receptor‐positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics
por: Xu, Yunjian, et al.
Publicado: (2023)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism
por: Yang, Hong, et al.
Publicado: (2011)

Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
por: Wang, Lin, et al.
Publicado: (2017)

Development and Validation of Novel Nomograms Using Serum Tumor Markers for the Prediction of Preoperative Histologic Grades in Gastroenteropancreatic Neuroendocrine Tumors
por: Li, Yan, et al.
Publicado: (2021)

Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex
por: Tie, Yan, et al.
Publicado: (2020)

Targeted Nanoparticles for Fluorescence Imaging of Folate Receptor Positive Tumors
por: Marko, Aimee J., et al.
Publicado: (2020)

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
por: Li, Yang, et al.
Publicado: (2019)

The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology
por: Song, Gang, et al.
Publicado: (2019)

A preliminary study of the clinical significance of folate receptor-positive circulating tumor cell in the management of hepatobiliary-pancreatic cancers
por: He, Yong-gang, et al.
Publicado: (2020)

Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study
por: Liu, Jingbo, et al.
Publicado: (2019)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
por: Cheng, Xinyu, et al.
Publicado: (2023)

Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– Positive circulating tumor cells and HSP90
por: Huang, Maosen, et al.
Publicado: (2022)

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse
por: Wang, Huanrong, et al.
Publicado: (2023)

Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
por: Kelemen, Linda E., et al.
Publicado: (2014)

Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands
por: Hu, Yingwen, et al.
Publicado: (2022)

Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
por: Yu, Jing, et al.
Publicado: (2021)

Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management
por: Marsland, Thomas, et al.
Publicado: (2014)

Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy
por: Shen, Jiqiao, et al.
Publicado: (2017)

Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
por: Jiang, Rifeng, et al.
Publicado: (2017)

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

Folate transporter dynamics and therapy with classic and tumor-targeted antifolates
por: O’Connor, Carrie, et al.
Publicado: (2021)

Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors
por: Aung, Winn, et al.
Publicado: (2022)

Histological classification and expression of markers of canine mast cell tumors
por: Cruz, V. S., et al.
Publicado: (2020)

Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients
por: Zhao, Jia-Xing, et al.
Publicado: (2017)

The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
por: Jiang, Chunyang, et al.
Publicado: (2022)

Serum folate levels and hypertension
por: Lee, Yoonkyung, et al.
Publicado: (2022)

Synthesis of folate-chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells
por: Cheng, Lichun, et al.
Publicado: (2017)

Histological patterns of head and neck tumors: An insight to tumor histology
por: Dive, Alka M, et al.
Publicado: (2014)

Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies
por: Wang, Rong, et al.
Publicado: (2014)

Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer
por: Chen, Xiaoxia, et al.
Publicado: (2020)

Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study
por: Zeng, Ci Dian Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nbj4qm3552vu5mo6j82ddr59pr